All articles by Praveen Duddu

Twitter: Dr Toni Choueiri – FDA approval of pembrolizumab – top tweet Q4 2021

Metabolic disorders therapy area most suitable for use of digital health tech in clinical trials: poll

Verdict has conducted a poll to assess which therapy areas are most suitable for the use of digital health technologies in clinical trials.

Concerns over the spread of COVID-19 declining since June: Poll

Fear of COVID-19 community transmission has been causing anxiety among the public as well as governments.

mRNA vaccines the most promising among emerging COVID-19 vaccines: Poll

COVID-19 poll: Disrupted clinical trials will take six to 12 months to return to normal

The COVID-19 pandemic significantly disrupted ongoing clinical trials in various stages, with more than 1,000 trials by sponsors, collaborators, or contract research organisations having gone off the trial schedules.

Approved COVID-19 vaccine could be available in six months; high-risk groups should get priority access: Poll

The global spread of the COVID-19 pandemic and the resulting economic impact and public health burden has highlighted the urgent need for a vaccine to prevent the disease

Few employees want to return to office full-time when lockdowns are eased: Poll

Remote working or working from home has become the new norm during the COVID-19 times which call for maintaining physical distancing and complying with lockdown measures to curb disease spread.

Optimism over global economic recovery hits a low as May ends: Poll analysis

COVID-19 concerns increase in May following easing of lockdowns

Coronavirus treatment: Vaccines/drugs in the pipeline for COVID-19

Here are the potential human coronavirus vaccines/drugs pharmaceutical companies across the world are developing following the Wuhan coronavirus outbreak (COVID-19).